Suchergebnisse - "Fischer-Valuck, Benjamin W"

PubPharm (68)

1

Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?

enthalten in: Clinical genitourinary cancer | 2023

von Andruska, N. | Waters, M. | Fischer-Valuck, B. | +10

2

Benchmarking the Radiation Oncology Alternative Payment Model : Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment Courses

enthalten in: Practical radiation oncology | 2023

von Hogan, J. | Karraker, P. | Fischer-Valuck, B. | +6

3

Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer : The Impact of Primary versus Secondary Pattern 5

enthalten in: Brachytherapy | 2023

von Patel, S. | Baumann, B. | Michalski, J. | +8

4

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy

enthalten in: Cureus | 2023

von Waters, M. | Andruska, N. | Fischer-Valuck, B. | +5

5

Prospective imaging comparison of anatomic delineation with rapid kV cone beam CT on a novel ring gantry radiotherapy device

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2023

von Henke, L. | Fischer-Valuck, B. | Rudra, S. | +12

6

Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy

enthalten in: Brachytherapy | 2022

von Andruska, N. | Agabalogun, T. | Fischer-Valuck, B. | +6

7

Decreases in Radiation Oncology Medicare Reimbursement Over Time : Analysis by Billing Code

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Hogan, J. | Roy, A. | Karraker, P. | +8

8

Reply by Authors

enthalten in: The Journal of urology | 2022

von Andruska, N. | Fischer-Valuck, B. | Waters, M. | +9

CommentOn: J Urol. 2022 Jun;207(6):1234-1235. - PMID 35282698

9

Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy

enthalten in: The Journal of urology | 2022

von Andruska, N. | Fischer-Valuck, B. | Waters, M. | +9

CommentIn: J Urol. 2022 Jun;207(6):1234-1235. - PMID 35282698

10

Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer

enthalten in: Brachytherapy | 2022

von Andruska, N. | Michalski, J. | Carmona, R. | +5

1
2
3
4
5
6
7
Nächster »
[7]